Jazz Pharmaceuticals plc is a dynamic specialty biopharmaceutical company that identifies, develops and commercializes innovative products to address unmet medical needs in focused therapeutic areas, always keeping in mind our mission to improve patients’ lives. Our unwavering commitment to advancing patient care is demonstrated every day. Living our core values of integrity, passion, collaboration, innovation and the pursuit of excellence is the key to our success. Headquartered in Dublin, Ireland with locations in California and Pennsylvania, the company is committed to working closely with patients, patient advocacy groups and healthcare professionals. Jazz Pharmaceuticals markets a diverse portfolio of products in the areas of narcolepsy, oncology, pain and psychiatry.
Webcast ImageWebcast
Q3 2014 Jazz Pharmaceuticals Earnings Conference Call (Live)
11/04/14 at 4:30 p.m. ET
Press Releases
Oct 21 2014 - 4:05 p.m.
Jazz Pharmaceuticals to Report 2014 Third Quarter Financial Results on November 4, 2014
Aug 08 2014 - 6:30 a.m.
Jazz Pharmaceuticals Announces Pricing of $500 Million of Exchangeable Senior Notes
Aug 06 2014 - 4:05 p.m.
Jazz Pharmaceuticals Announces Proposed Offering of $500 Million of Exchangeable Senior Notes


Sign up to receive e-mail alerts whenever Jazz Pharmaceuticals posts new information to the site. Just enter your e-mail address and click Submit.